nerolidol has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, A; Alonso, L; Dorta, ML; Fernandes, KS; Gomes, RS; Gonçalves, PJ; Mendanha, SA | 1 |
| Cho, MH; Kim, SI; Lee, J; Lee, JH; Lee, K | 1 |
2 other study(ies) available for nerolidol and Hemolysis
| Article | Year |
|---|---|
In vitro antileishmanial and cytotoxic activities of nerolidol are associated with changes in plasma membrane dynamics.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Cell Membrane; Electron Spin Resonance Spectroscopy; Hemolysis; Leishmania; Membrane Fluidity; Mice; Mice, Inbred BALB C; Sesquiterpenes | 2019 |
Anti-biofilm, anti-hemolysis, and anti-virulence activities of black pepper, cananga, myrrh oils, and nerolidol against Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Cananga; Disease Models, Animal; Gene Expression Profiling; Hemolysis; Oils, Volatile; Piper nigrum; Sesquiterpenes; Staphylococcus aureus; Survival Analysis; Terpenes; Virulence | 2014 |